Alemtuzumab reduces disease activity in treatmentnaive patients with highly active relapsing-remitting multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: 568518787db5b99b77b96468d7a2fcf07e874515
First added on: Apr 30, 2026